Dalton Pharma Services: Orphan Drugs

Dalton Pharma Services is excited to share our whitepaper on orphan drugs. Discover how Dalton can help with rare disease innovations and learn more about global regulatory frameworks for orphan drugs. 

Check out our whitepaper today!

Whitepaper: Orphan Drugs

Inquire today at bd@dalton.com to see how we can help with your next project.

About Dalton Pharma Services:

Dalton Pharma Services is a leading North American cGMP pharmaceutical organization providing integrated drug discovery, development and manufacturing services. We are FDA inspected and Health Canada approved and bring over 30 years of experience to every project. We deliver fully integrated solutions with an emphasis on speed, flexibility and quality. Our integrated services (drug discovery, formulation and process development, custom synthesis, cGMP sterile fill/finish of liquids and powders, cGMP API manufacturing and/or dosage form manufacturing and Accelerated Stability Testing) all at one location helps us to be adaptable, flexible and cost-effective.

To learn more about our history and capabilities, please visit https://www.dalton.com.

Peter Pekos
CEO
Dalton Pharma Services
349 Wildcat Road
Toronto, Ontario
Tel: 416-661-2102